Search by Drug Name or NDC

NDC 65162-0735-50 Felbamate 600 mg/1 Details

Felbamate 600 mg/1

Felbamate is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Amneal Pharmaceuticals LLC. The primary component is FELBAMATE.

MedlinePlus Drug Summary

Felbamate is used to treat certain seizures in adults and children with epilepsy whose seizures have not improved with other treatments. It is used alone or in combination with other medications to treat partial seizures in adults. It is used in combination with other medications to treat partial and generalized seizures in children with Lennox-Gastaut syndrome (a disorder that causes seizures and developmental delays). Felbamate is in a class of medications called anticonvulsants. It works by decreasing abnormal activity in the brain.

Related Packages: 65162-0735-50
Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Felbamate

Product Information

NDC	65162-0735
Product ID	65162-735_6650d6ff-cc06-4bea-a3fe-135b9b07e881
Associated GPIs	72120020000320
GCN Sequence Number	020042
GCN Sequence Number Description	felbamate TABLET 600 MG ORAL
HIC3	H4B
HIC3 Description	ANTICONVULSANTS
GCN	38022
HICL Sequence Number	008186
HICL Sequence Number Description	FELBAMATE
Brand/Generic	Generic
Proprietary Name	Felbamate
Proprietary Name Suffix	n/a
Non-Proprietary Name	Felbamate
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	TABLET
Route	ORAL
Active Ingredient Strength	600
Active Ingredient Units	mg/1
Substance Name	FELBAMATE
Labeler Name	Amneal Pharmaceuticals LLC
Pharmaceutical Class	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA201680
Listing Certified Through	2024-12-31

Package

NDC 65162-0735-50 (65162073550)

Pricing Information	N/A
NDC Package Code	65162-735-50
Billing NDC	65162073550
Package	500 TABLET in 1 BOTTLE (65162-735-50)
Marketing Start Date	2011-09-16
NDC Exclude Flag	N